cardiovascular drugs

When Price Dictates TreatmentWhen drug prices spike, health-care providers are forced to make tough choices.
Cardiovascular drugs: Current spending, future outlookCardiovascular drugs are among the most widely used, since their indications are far reaching and address conditions that are prevalent among a large population.
Top 3 cardiovascular patient compliance challenges
Top 3 cardiovascular patient compliance challengesStaying compliant with a prescribed treatment regimen gives cardiovascular disease patients the best chance of improving their heart health and reducing future incidences of cardiac events. Here’s how to get patients on board.
FDA denies claims for Zetia, VytorinFDA declined to approve Merck’s claim that its cholesterol-lowering drugs Zetia and Vytorin reduce the risk of heart attacks and strokes in patients with coronary heart disease.
Payer issues with new heart failure drugEntresto is the first in a new class of drugs, valsartan combined with sacubitril, a pro-drug of a compound that is a receptor‐neprilysin inhibitor (ARNI). It is taken orally twice daily. It was approved for heart failure patients with reduced ejection fraction based on the PARADIGM-HF trial.
Americans at risk for alcohol-drug interactionsHealthcare providers need to help patients understand how alcohol can interact with their medications, according to a study from the National Institutes of Health and published in the February 2015 issue of Alcoholism: Clinical and Experimental Research.
Novartis heart failure drug fails to win FDA approvalFDA has decided not to approve acute heart failure drug serelaxin (Novartis).
Preventing stroke in the elderly may be excessivePatients more than 80 years old are being “over-treated” for stroke prevention and doctors need to actively rethink their priorities and beliefs about stroke prevention, according to a new study published in Evidence Based Medicine.
New migraine options neededThe American Migraine Prevalence and Prevention (AMPP) Study recommends new options for those with cardiovascular event histories who also need migraine treatment
5 most expensive Rxs for retireesAmericans 65 and older spent nearly $93 billion on prescription drugs in 2010. That’s not surprising. What may be surprising is that nearly 7 out of 10 of those dollars were spent in only a handful of drug classifications.